Ahead of the new wave of morbidity:
Maccabi Health Services published today (Tuesday) the morbidity data, according to which there was an increase in the number of vaccinators and the number of tests.
The data show that between June 5-9, about 20,500 members were examined from the fund to the corona, the following week about 32,000 members were examined - an increase of 55% - and the following week about 41,000 members were examined for the detection of the corona virus - an increase of 30%.
In total, from the beginning of the month until the end, there is a 100% increase in the performance of corona tests.
The HMO also shared that about 10,000 members were examined last Sunday.
On the same day, the 5 million tests were performed in the national laboratory of Maccabi Health Services to detect the corona virus since the onset of the epidemic.
About 4,400 tests came out positive, a similar figure was in the past for the last time in early April.
Maccabi data also show that between June 6-9, about 8,100 verified members were found in Corona, the following week about 13,000 new verified people were discovered - an increase of 60% - and the following week about 18.1 thousand new verified people were discovered in Corona - an increase of 40% .
In total, from the beginning of the month to the end, there was a 123% increase in the number of new verified corona.
Paxlobid drugs arrived in Israel, Photo: AP
In terms of vaccinators, the data show that between June 6-9, we vaccinated (all rations, all ages) about 1,350 Maccabi members, in the following week we vaccinated about 2,700 Maccabi members - an increase of 100% - and the following week we vaccinated about 3,600 Maccabi members throughout the country - an increase of 35%.
In total, from the beginning of the month until the end, there was an increase of 160% among the number of vaccinated in Maccabi.
There was also an increase in the administration of the faxlobid drug for treatment in Corona, and the data show that between June 6-9, about 400 insured received the drug, the following week about 720 insured - an increase of 80% - and the following week received the drug about 940 insured - an increase of 30%.
In total, from the beginning of June until the end, there was a 140% increase among faxlobide recipients for treatment with corona among Maccabi members.
"We are witnessing a sharp increase in coronary heart disease data, which is a result of the decision to live alongside the epidemic, and not live the epidemic," said the head of Maccabi Health Services' health division, Dr. Miri Mizrahi Reuveni, referring to the data.
"A result of the decision to live alongside the plague, and not to live the plague."
Dr. Miri Mizrahi - Reuveni, Photo: Daniel Hermon
She added that "we are prepared to provide an ongoing response to our members, from the time the tests are performed, through the continued administration of the vaccines to the issuance of Corona drugs to high-risk populations.
I recommend everyone to wear a mask indoors, and especially to high-risk populations.
Each of us has a parent or relative at risk at home, which raises the importance of the matter.
Anyone who has not yet been vaccinated against the virus - we recommend that he complete the vaccine and protect himself and his environment. "
Were we wrong?
Fixed!
If you found an error in the article, we would love for you to share it with us
